developing countries in Latin America?

Similar documents
Sustaining Immunization in Developing Countries: The Future We Make

Introduction of New Vaccines in Latin America and the Caribbean: Decision-Making LUCIA HELENA DE OLIVEIRA AND BARBARA JAUREGUI

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

Using surveillance data to monitor impact of rotavirus vaccine. Lúcia De Oliveira Regional Advisor on New Vaccines IM/PAHO

Update on Transition: the case of Honduras. Minister Dra Yolani Batres AMRO/EURO Gavi Constituency Representative Geneva June 2016

Accelerating the Introduction of Rotavirus Vaccines into GAVI-Eligible Countries

144th SESSION OF THE EXECUTIVE COMMITTEE

Progress Toward Rubella and Congenital Rubella Syndrome Elimination in the Western Hemisphere,

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

Vaccines Supply Shortages Challenges & Opportunities

Can we improve the performance of live oral rotavirus vaccines?

52nd DIRECTING COUNCIL 65th SESSION OF THE REGIONAL COMMITTEE

Taking vaccine effectiveness into public health decision making: The ProVac Example

Strengthening evidence-based decision making for new vaccine introduction: PAHO s ProVac Initiative

Global Immunization Vision and Strategies (GIVS) Vaccine Tender , Pretender Meeting, Copenhagen December 2008

Last mile vaccine distribution to rural health centres. Faheem Merchant

Understanding the Roles of Different Bodies in Vaccine Decision Making: The Caribbean EPI Experience

Influenza Vaccine Use In the Americas

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS

Rotavirus vaccines: Issues not fully addressed in efficacy trials

Monitoring For Rotavirus Serotypes In The Americas. Jon Gentsch

Vaccines against Rotavirus & Norovirus. Umesh D. Parashar CDC, Atlanta, GA

A Briefing Paper on Rotavirus

Update on Pentavalent Human-Bovine Rotavirus Vaccine. Michelle Goveia, MD, MPH Medical Director MSD Vaccines India, September 2014

Global Health Policy: Vaccines

Value of post-licensure data to assess public health value Example of rotavirus vaccines

Common Virus and Senseless Killer: A Briefing Paper on Rotavirus

Alternative Rotavirus Vaccine Candidates: Why should we bother?

Introduction to the ProVac Initiative

FOURTH ANNUAL VACCINATION WEEK IN THE AMERICAS (VWA 2006) FINAL REPORT

Rotavirus: WHO Global Recommendations, Policy, and Surveillance

Rotavirus vaccine impact on diarrhea associated child mortality, hospital admissions & clinical visits in Bolivia

Championing Health: Sustainable Development and Equity. PAHO Strategic Plan

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007

ROTAVIRUS COMMON, SEVERE, DEVASTATING, PREVENTABLE [ ] THE LATEST EVIDENCE & WHAT S NEEDED TO STOP ILLNESSES AND DEATHS

Global Vaccine Action Plan (GVAP)

Zika Operation: IMPACT IN THE AMERICAS. Americas Regional Office

Conclusions and Recommendations of the Experts Meeting on Rotavirus Genotypes in the Region of the Americas

Progress Made in the Integration of EPI Costing and Planning

GAVI RESOURCE GAP ALWAYS BEEN AN ISSUE

Regional Immunization Action Plan for the Americas Progress report 2015

Gisele Almeida Public Policies, Regulation, and Health Financing Health Systems and Services

Overview of the First Regional Dengue Symposium Rio de Janeiro, Brazil, 3-4 November 2015

1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector

HPV Vaccines: Background and Current Status

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

WHITE PAPER. A Summary of Global Immunization Coverage through David W Brown, Anthony H Burton, Marta Gacic-Dobo (alphabetical order)

Shabir A. Madhi. Progress and Challenges of Immunization Contributing Toward Attaining the MDG Goal to Reduce under-5 Childhood Mortality.

GSK VACCINES: KEY GROWTH DRIVERS

Disease Control Priorities. Presentation Sub-title Seventh International Rotavirus Symposium Lisbon June 12, 2006

Dr Michelle Groome MBBCh (Wits) DCH(SA) MScMed (Epi & Biostats) Department of Science and Technology/National Research Foundation: Vaccine

THIRTY-FIRST MEETING OF THE CARIBBEAN IMMUNIZATION MANAGERS FINAL REPORT

Vaccine Hesitancy: Acceptance and demand of vaccines in the Americas

Roger I. Glass, M.D., Ph.D. Director, Fogarty International Center Associate Director for International Research, NIH

Regional Update Influenza (August 16, h GMT; 12 h EST)

Lessons Learned and Best Practices of Achieving and Maintaining Measles and Rubella Elimination in the Americas

Vaccines. Global impact of a preventive technology. Edwin J. Asturias, MD

Global Vaccine Action Plan

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer

Targeted Diseases and Immunization. Strategic plan

From development to delivery: Decision-making for the introduction of a new vaccine

Rotavirus Vaccine. Supply and Procurement Roadmap. The Market Shaping Goal. Public Summary. Rotavirus Supply and Procurement Roadmap UPDATE 2016

GAVI partners Forum, Dar es Salaam, Tanzania December 5-7, 2012

Dr. Bernd Benninghoff GSK Vaccines, GML Global Medical Affairs Director

Challenges of use of cholera vaccines in Haiti and the Americas

Vaccines. Global impact of a preventive technology. Edwin J. Asturias, MD

Action plan for the health sector response to viral hepatitis in the WHO European Region

Exercise: Estimating immunization program costs (~60 minutes)

Overview of the ProVac Initiative

REVELAC-i: Progress in measuring influenza vaccine effectiveness in Latin America and way forward

FINAL REPORT TECHNICAL ADVISORY GROUP ON VACCINE-PREVENTABLE DISEASES AUGUST 2009, COSTA RICA

CD29/23 Page 2. (Eng.) EXPANDED PROGRAM ON IMMUNIZATION IN THE AMERICAS. Progress Report by the Director. 1. Background and Policy Basis

Rotavirus Vaccines. Gagandeep Kang Christian Medical College Vellore

Vaccine Pricing: Gavi Transitioning Countries

Rotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division

30 th Caribbean Immunization Managers Meeting

Access to vaccination in GAVI countries and at global level

Hepatitis B and C in the Spotlight: A public health response in the Americas. Key Messages

REGIONAL STRATEGY AND PLAN OF ACTION FOR CERVICAL CANCER PREVENTION AND CONTROL IN LATIN AMERICA AND THE CARIBBEAN

Vaccine Decision-Making

An aggressive approach for measles outbreak among adolescents in Barranquilla, Colombia, 2011

Senior Management Team Meeting Target setting in Latin America

Task Force on Immunization (TFI) in Africa 14 th Annual Meeting. And. Africa Regional Inter-Agency Coordination Committee (ARICC) 13 th Annual Meeting

Regional Update Pandemic (H1N1) 2009 (July 6, h GMT; 12 h EST)

Rubella and CRS Elimination in the Americas

B. PLAN OF ACTION FOR IMPLEMENTING THE GENDER EQUALITY POLICY

Retrospective Analysis of Volume Guarantees in the Pentavalent and Rotavirus Vaccine Markets

Regional Update Pandemic (H1N1) 2009 (July 19, h GMT; 12 h EST)

Global Health Policy: Vaccines

TERMS OF REFERENCE. Regional Immunization Program. Department of Family, Gender and Life Course

20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus since April 2009.

Pandemic (H1N1) (August 28, h GMT; 12 h EST) Update on the qualitative indicators

Vaccine Innovation: Challenges and Opportunities to Protect Health. Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines

Measles Containing Vaccines. UNICEF Supply Division Industry Consultation Meeting January 2012

New Vaccines in SA. Regulatory Perspectives James Southern 2015

TWENTY-THIRD CARIBBEAN EPI MANAGERS MEETING FINAL REPORT

Edwin J. Asturias, MD Department of International Health Johns Hopkins Bloomberg School of Public Health. University del Valle in Guatemala

Introduction and overview of the program; new vaccine pipeline and prioritization process

DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American Health Organization/ World Health Organization

Transcription:

. How have rotavirus vaccines worked in developing countries in Latin America? Brendan Flannery, Pan American Health Organization, Brazil and Lúcia De Oliveira, Immunization Unit/FCH, Washington, DC 9th International Rotavirus Symposium, Johannesburg, South Africa, August 2-3, 2010

How have rotavirus vaccines worked in developing countries in the Americas Political support Rotavirus surveillance network Disease burden and cost effectiveness Vaccine introduction Impact of vaccination Special studies Lessons learned

Political support

Pan American Health Organization s (PAHO) Regional Immunization Program Reduce inequities in health between resourcewealth and resource poor countries Political commitment, technical, operational and financial support Providing new and underutilized vaccines to the children and families who need them

Resolution by Ministers of Health, PAHO Directing Council meeting in 2006 Support WHO s Global Immunization Vision and Strategy and the Millennium Development Goals Resolve to mobilize additional funding to sustainably introduce new vaccines against rotavirus, pneumococcal and human papillomavirus Of 20 countries with highest under 5 mortality, 13 have introduced rotavirus vaccines Latin American countries on track to meet MDG4

Financing immunization programs National support for EPI: 93% is financed by governments Vaccine price, PAHO s Revolving Fund, 2009: Rotarix: US$ 7.50 /dose, $15 /child RotaTeq: US$ 5.50 /dose, $16.5 /child Rotavirus vaccine represents 97.3% of the cost of the basic immunization schedule of countries (OPV, DPT, Hib, HepB, MMR) GAVI countries: Bolivia and Honduras approved by GAVI, Guyana financed on its own

Rotavirus surveillance network

PAHO Guidelines Field guide Epidemiologic surveillance of Diarrheal diseases due to rotavirus Field guide on Introduction of New Vaccines based on WHO Guidelines

Countries participating in rotavirus surveillance network

Percent rotavirus-positive samples from children <5 hospitalized for diarrhea in participating countries, 2006-2007 De Oliveira, Rotavirus Surveillance in Latin American and Caribbean, JID 2009

Seasonality of hospitalizations for rotavirus in participating countries, 2006 2007 Northern hemisphere Southern hemisphere De Oliveira, Rotavirus Surveillance in Latin American and Caribbean, JID 2009

Disease burden and cost effectiveness

Causes of death among children <5 years in the Americas, 2008 Black et al., Lancet, 12 May 2010

Estimates of rotavirus disease burden in the Region of the Americas 15,000 deaths 75,000 hospitalizations 2 million clinic visits 10 million cases of rotavirus diarrhea Source: De Oliveira, Expert Rev. Vaccines, 2008

Cost-effectiveness Introduction of new vaccines needs to be grounded in evidence that they are cost effective: PRO-VAC: 5 years strategic plan to strengthen national capacity to make evidence-based decisions for new vaccines http://new.paho.org/provac/

Vaccine introduction

Rotavirus vaccine introduction Latin American countries : first countries to introduce rotavirus vaccine in public health sector: March 2006 in Panama As of May 2010, 14 countries and one territory had introduced rotavirus vaccine: 13 - Rotarix (GSK) 2 - RotaTeq (Merck)

Introduction of rotavirus vaccines in Latin America, 2006-2010 Countries and total population <1 year 16 10000 Number of coun ntries 14 12 10 8 6 4 2 9000 8000 7000 6000 5000 4000 3000 2000 1000 Children <1 year (th housands) 0 2006 2007 2008 2009 2010 0

Latin America and Caribbean countries with rotavirus vaccines into their routine schedules

Age in weeks at vaccination, Nicaragua and Brazil RotaTeq, Nicaragua Dose 1 Dose 2 Dose 3 Rotarix, Brazil

Comparison of first dose coverage for RotaTeq vs. DPT-HepB-Hib, Nicaragua, 2007 (RotaTeq introduced October 2006) Orozco et al., Uptake of rotavirus vaccine, Nicaragua, JID 2009

Rotavirus and DPT coverage for 8 Latin American countries, 2009 % co overage 100 90 80 70 60 50 40 30 20 10 0 RV2/3 DTP3 Source: Country reports

Impact of vaccination

Diarrhea and rotavirus related admissions among children <5 years at seven hospitals, El Salvador, January to June,* 2006-2009

ERROR: stackunderflow OFFENDING COMMAND: ~ STACK: